600249, planning a control change! Trading will be suspended next Monday! "Stock speculation" caused an 88% drop in performance, yet the stock price soared!

MaticHoleFiller · 2026-03-29T23:50:32+00:00

Liangmianzhen (600249) announced that trading will be suspended as it plans an equity transfer, with the controlling shareholder holding 35.68% of shares. The 2025 performance report shows a slight increase in revenue but a sharp 87.86% decline in net profit, mainly due to stock trading losses. Recently, the stock price has experienced significant volatility, with a total increase of 20.19%.

MaticHoleFiller

2026-03-29 23:50:32

Abstract generation in progress

If you want to trade stocks, just look at the Jin Qilin analyst research reports—authoritative, professional, timely, and comprehensive—helping you uncover potential thematic opportunities!

Two-Sided Needles (600249) announced on the evening of March 27 that its controlling shareholder, Guangxi Liuzhou Industrial Investment and Development Group Co., Ltd. (hereinafter “Industrial Group”), is in the process of planning the transfer of the company’s shares it holds. The company’s stock will be suspended from trading starting from the opening of trading next Monday morning, and the suspension is expected to last no more than 2 trading days. The listed company said that, at present, the Industrial Group and the counterparty are actively advancing the relevant work for this transaction, and there is still uncertainty regarding the matter.

Currently, the Industrial Group and its related parties collectively hold 35.68% equity in Two-Sided Needles, of which the Industrial Group holds 33.34%.

On March 26, Two-Sided Needles disclosed its 2025 performance. The annual report shows that in 2025, Two-Sided Needles achieved total operating revenue of 1.063 billion yuan, up slightly by 0.90% year over year; attributable net profit was 9.8461 million yuan, down significantly by 87.86% year over year; and profit after deducting non-recurring items was 4.2798 million yuan, down 52.17% year over year.

Notably, the decline in Two-Sided Needles’ performance is mainly due to “stock trading.” The annual report shows that in 2025, Two-Sided Needles recorded a fair value change gain on trading financial assets of -4.4282 million yuan. This loss mainly resulted from the decline in the share price of the China Citic Securities stock held by the company; in 2024, the gain for this item was 87.7418 million yuan, contributing 108% of the company’s net profit for that year.

This week, Two-Sided Needles’ stock price has shown clear unusual movement. After the stock price fell 9.86% on Monday, it saw four consecutive days of gains. Over 4 trading days, the stock price累计 increased by 20.19%. Today, it even surged by 5.99%. The latest closing price is 6.37 yuan per share, and the market value is 3.5 billion yuan.

This week, multiple A-share companies have issued announcements regarding plans to change control. On the evening of March 25, Fuyun Transport announced that its controlling shareholder is planning a share transfer, which may lead to a change in control. On the evening of March 23, TaiFufeng Pump Industry announced that the actual controller is planning matters related to a change in control. Both companies are under suspension.

A huge amount of information and precise interpretation—right in the Sina Finance app

责任编辑：杨红卜

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.